NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Investor Presentation, 14 March 2023, page-9

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735
    As I posted earlier Acadia not only mentioned Fragile X last night but other conditions ‘they would not discuss publicly’
    i don’t think they’ll sit on as asset as valuable as Daybue. They might take some months to catch their breathe but as a company investors always want to see growth potential, so I’d be happy with an some indication of a forward looking plan at any stage this year from them
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.